Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression: a Double-blind, Randomized Controlled Trial

NCT06524505 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT06524505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression: a Double-blind, Randomized Controlled Trial
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2024
Completion date
February 28, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression